Phase IIIb preterm delivery study expands to additional locations in Serbia, Romania, and Bulgaria under GCT management, making our team responsible for this project at 45 sites in 7 countries.
The Sponsor, a US pharmaceutical company, thus shows confidence in GCT international capabilities and local expertise.